Lexeo Therapeutics, Inc. (LXEO)
NASDAQ: LXEO · Real-Time Price · USD
3.890
-0.140 (-3.47%)
Feb 21, 2025, 4:00 PM EST - Market closed
Lexeo Therapeutics Market Cap
Lexeo Therapeutics has a market cap or net worth of $128.67 million as of February 21, 2025. Its market cap has decreased by -70.36% in one year.
Market Cap
128.67M
Enterprise Value
-17.95M
1-Year Change
-70.36%
Ranking
Category
Stock Price
$3.89
Market Cap Chart
Since the IPO on November 3, 2023, Lexeo Therapeutics's market cap has decreased from $271.36M to $128.67M, a decrease of -52.58%. That is a compound annual growth rate of -43.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 128.67M | -40.88% |
| Dec 31, 2024 | 217.65M | -39.13% |
| Dec 29, 2023 | 357.58M | 31.78% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 785.37B |
| UnitedHealth Group | 463.73B |
| Johnson & Johnson | 378.19B |
| Novo Nordisk | 365.53B |
| AbbVie | 347.77B |
| AstraZeneca | 230.61B |
| Abbott Laboratories | 227.70B |
| Intuitive Surgical | 215.59B |